Descripción del proyecto
Nuevas herramientas para el diagnóstico precoz de los trastornos auditivos
La exposición a niveles de ruido inseguros supone una amenaza para la salud auditiva de hasta el 60 % de la población europea. En este contexto, el equipo del proyecto EDHI, financiado por las Acciones Marie Skłodowska-Curie, pretende desarrollar un conjunto de herramientas innovadoras capaces de detectar los señales iniciales de la pérdida de audición y proporcionar un diagnóstico precoz. Esto se conseguirá mediante la creación de nuevas pruebas conductuales y neurofisiológicas que puedan identificar biomarcadores particulares del rendimiento auditivo. Además, se creará un clasificador automático para evaluar el alcance del daño auditivo basándose en estos biomarcadores. El equipo de EDHI recurrirá a datos piloto y su conocimiento especializado en métodos avanzados de procesamiento de señales e investigación auditiva con el fin de diagnosticar trastornos auditivos que a menudo pasan desapercibidos, lo que permitirá formular recomendaciones individualizadas para cada caso.
Objetivo
Approximately 40–60% of the European population is at risk of developing hearing loss due to exposure to unsafe noise levels. The EDHI fellowship will develop a novel toolkit sensitive to the first signs of hearing loss – appropriate for use as an early diagnostic. This objective will be achieved by (1) ideating innovative behavioural and neurophysiological tests that will provide novel biomarkers of hearing performance, and (2) developing an automatic classifier that estimates the degree of hearing damage based on these biomarkers. The encouraging pilot data obtained to date, along with the background experience of the applicant and supervisor in developing advanced signal-processing methods and conducting hearing research situate them in an optimal position to conduct the planned research. This fellowship has the potential to transform current clinical practice by providing clinicians with the necessary tools to diagnose hearing disorders that are currently undetected in approximately 1 out of 10 patients. The early diagnosis of hearing difficulties will enable the provision of individualised recommendations to ameliorate a person’s hearing difficulties and prevent any further deterioration, thus reducing the risk of social isolation, anxiety, depression and dementia. Further, a ‘hearing-pathology demonstrator’ will be developed for use in outreach activities to increase awareness amongst the general population of the adverse impacts of hearing loss, and to assist policy makers in the design of effective prevention strategies. In addition, this fellowship lays the groundwork for a substantial bidirectional transfer of knowledge with the host institution and provides the opportunity to engage with top hearing-related industry partners who have an interest in the commercial exploitation of this technology.
Ámbito científico
Palabras clave
Programa(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Régimen de financiación
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European FellowshipsCoordinador
18071 Granada
España